Development of a Device to Objectively Measure Pain (R43/R44)

The summary for the Development of a Device to Objectively Measure Pain (R43/R44) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Development of a Device to Objectively Measure Pain (R43/R44): The purpose of this Small Business Innovation Research (SBIR) Funding Opportunity Announcement (FOA) is to develop a technology/device that objectively indicates the presence and level of pain.

Federal Grant Title:	Development of a Device to Objectively Measure Pain (R43/R44)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DA-18-012
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Information not provided
Current Application Deadline:	December 5th, 2017
Original Application Deadline:	December 5th, 2017
Posted Date:	July 12th, 2017
Creation Date:	July 12th, 2017
Archive Date:	January 10th, 2018
Total Program Funding:	$3,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	July 12th, 2017

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-012.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional); • Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H...; • Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeu...; • CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical...; • Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development (HBCD) St...; • HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - R...; • Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional); • Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on H...; • NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clini...